Contract 75N91024D00003
The Institute For Cancer Research · Department Of Health And Human Services · April 28, 2026
The Institute For Cancer Research was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on April 28, 2026 for an undisclosed amount of work in research and development in biotechnology (except nanobiotechnology). It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. The most recent modification was on June 29, 2026. If all options are exercised, the contract could reach $150.00 million.
Contract details
- PIID
- 75N91024D00003
- Award type
- Indefinite Delivery / Indefinite Quantity
- Pricing
- Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- First action
- April 28, 2026
- Latest action
- June 29, 2026
Description
EO 14398 PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
Modification timeline
-
June 29, 2026Mod P00004 · Supplemental Agreement For Work Within Scope$0
-
April 28, 2026Mod P00003$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Battelle Memorial Institute | Department Of Health And Human Services | July 2, 2026 | $6.28M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | July 2, 2026 | $597.8K |
| Medigen, Inc. | Department Of Health And Human Services | July 2, 2026 | $2.18M |
| American Type Culture Collection | Department Of Health And Human Services | July 1, 2026 | $855.4K |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $11.71M |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $3.49M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91024D00003?
Contract 75N91024D00003 is a federal contract awarded to The Institute For Cancer Research by Department Of Health And Human Services on April 28, 2026 for an undisclosed amount of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75N91024D00003?
The Institute For Cancer Research won contract 75N91024D00003 from Department Of Health And Human Services.
How much is contract 75N91024D00003 worth?
Contract 75N91024D00003 has obligated $0 to date but carries a potential ceiling of $150.00 million if fully funded and all options are exercised.